Madrigal Pharmaceuticals (MDGL) Intangibles (2024 - 2026)
Madrigal Pharmaceuticals (MDGL) reported Intangibles of $7.3 million for Q1 2026, up 57.02% year-over-year from $4.6 million in Q1 2025, and down 1.31% quarter-over-quarter from $7.4 million in Q4 2025.
Madrigal Pharmaceuticals (MDGL) Intangibles (2024 - 2026) Analysis & Trends
Madrigal Pharmaceuticals (MDGL) has 3 years of Intangibles data on file, last reported at $7.3 million in Q1 2026.
- Intangibles for Q1 2026 came in at $7.3 million, up 57.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.3 million (up 57.02% YoY), and the FY2025 annual result was $7.4 million, up 56.08% from the prior year.
- Intangibles eased to $7.3 million in Q1 2026 per MDGL's latest filing, from $7.4 million in the prior quarter.
- Over five years, Intangibles peaked at $7.5 million in Q3 2025 and troughed at $4.5 million in Q2 2025.
- A 3-year average of $5.6 million and a median of $4.9 million in 2024 frame the typical range for Intangibles.
- The sharpest annual moves came in 2025 and 2026: Intangibles slipped 7.37% in 2025, then soared 57.02% in 2026.
- A 3-year view of Intangibles shows it stood at $4.7 million in 2024, then soared by 56.08% to $7.4 million in 2025, then decreased by 1.31% to $7.3 million in 2026.
- Business Quant data shows MDGL's Intangibles at $7.3 million in Q1 2026, $7.4 million in Q4 2025, and $7.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 7.73 Mn |
| 10 | Madrigal Pharmaceuticals | 14.67 Bn | 14.44 Bn | - | 7.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.28 Mn |
| Dec 31, 2025 | 7.38 Mn |
| Sep 30, 2025 | 7.48 Mn |
| Jun 30, 2025 | 4.55 Mn |
| Mar 31, 2025 | 4.64 Mn |
| Dec 31, 2024 | 4.73 Mn |
| Sep 30, 2024 | 4.82 Mn |
| Jun 30, 2024 | 4.91 Mn |
| Mar 31, 2024 | 5.00 Mn |